NDC Package 69097-364-36 Bleomycin

Injection Intramuscular; Intrapleural; Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69097-364-36
Package Description:
1 VIAL in 1 CARTON / 1 INJECTION in 1 VIAL
Product Code:
Proprietary Name:
Bleomycin
Non-Proprietary Name:
Bleomycin
Substance Name:
Bleomycin Sulfate
Usage Information:
Bleomycin is used to treat cancer. It works by slowing or stopping the growth of cancer cells. This medication may also be used to control the build-up of fluid around the lungs (pleural effusion) caused by tumors that have spread to the lungs. For this condition, bleomycin is placed in the space around the lungs through a chest tube.
11-Digit NDC Billing Format:
69097036436
NDC to RxNorm Crosswalk:
  • RxCUI: 1726673 - bleomycin 15 UNT Injection
  • RxCUI: 1726673 - bleomycin (as bleomycin sulfate) 15 UNT Injection
  • RxCUI: 1726673 - bleopmycin 15,000 IU Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Cipla Usa Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intrapleural - Administration within the pleura.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA209439
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-11-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69097-364-36?

    The NDC Packaged Code 69097-364-36 is assigned to a package of 1 vial in 1 carton / 1 injection in 1 vial of Bleomycin, a human prescription drug labeled by Cipla Usa Inc.. The product's dosage form is injection and is administered via intramuscular; intrapleural; intravenous; subcutaneous form.

    Is NDC 69097-364 included in the NDC Directory?

    Yes, Bleomycin with product code 69097-364 is active and included in the NDC Directory. The product was first marketed by Cipla Usa Inc. on March 11, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69097-364-36?

    The 11-digit format is 69097036436. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269097-364-365-4-269097-0364-36